GR970100333A - Φαρμακευτικα παρασκευασματα για ενδορρινικη χορηγηση - Google Patents

Φαρμακευτικα παρασκευασματα για ενδορρινικη χορηγηση

Info

Publication number
GR970100333A
GR970100333A GR970100333A GR970100333A GR970100333A GR 970100333 A GR970100333 A GR 970100333A GR 970100333 A GR970100333 A GR 970100333A GR 970100333 A GR970100333 A GR 970100333A GR 970100333 A GR970100333 A GR 970100333A
Authority
GR
Greece
Prior art keywords
intranasal administration
pharmaceutical preparations
absorption rate
pharmaceutical preparation
better absorption
Prior art date
Application number
GR970100333A
Other languages
English (en)
Inventor
Kosaka Yasuo
Ebata Tetsuo
Muramatsu Hiroshi
Takenaga Mitsuko
Igarashi Rie
Original Assignee
Ebata Tetsuo
Kosaka Yasuo
Fuji Yakuhin Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ebata Tetsuo, Kosaka Yasuo, Fuji Yakuhin Company, Limited filed Critical Ebata Tetsuo
Publication of GR970100333A publication Critical patent/GR970100333A/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR970100333A 1996-10-07 1997-08-27 Φαρμακευτικα παρασκευασματα για ενδορρινικη χορηγηση GR970100333A (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8282866A JP3020141B2 (ja) 1996-10-07 1996-10-07 経鼻投与用製剤

Publications (1)

Publication Number Publication Date
GR970100333A true GR970100333A (el) 1998-06-30

Family

ID=17658107

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970100333A GR970100333A (el) 1996-10-07 1997-08-27 Φαρμακευτικα παρασκευασματα για ενδορρινικη χορηγηση

Country Status (16)

Country Link
US (1) US5948749A (el)
JP (1) JP3020141B2 (el)
KR (1) KR19980032364A (el)
CN (1) CN1180569A (el)
AU (1) AU3992697A (el)
CA (1) CA2217409A1 (el)
DE (1) DE19740733A1 (el)
DK (1) DK114797A (el)
ES (1) ES2126536B1 (el)
FI (1) FI973244A (el)
FR (1) FR2754453A1 (el)
GB (1) GB2322077A (el)
GR (1) GR970100333A (el)
IT (1) IT1295047B1 (el)
NO (1) NO974618L (el)
SE (1) SE9703133L (el)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6835389B1 (en) 1998-08-26 2004-12-28 Teijin Limited Powder Composition for nasal administration
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ATE341562T1 (de) * 1999-06-30 2006-10-15 Takeda Pharmaceutical Verfahren zur darstellung von lh-rh-derivaten
US6382204B1 (en) 1999-10-14 2002-05-07 Becton Dickinson And Company Drug delivery system including holder and drug container
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
CA2519287A1 (en) 2003-03-27 2004-10-14 Bioactis Limited Powder medicine applicator for nasal cavity
EP1785145A4 (en) * 2004-08-10 2008-08-13 Translational Res Ltd TRANSNASAL COMPOSITION WITH IMMEDIATE EFFECT AND HIGH RESORBIBILITY
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
CN101027057B (zh) 2004-08-23 2017-04-12 曼金德公司 用于药物输送的二酮哌嗪盐、二酮吗啉盐或二酮二氧杂环己烷盐
US7115561B2 (en) * 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
FR2880272A1 (fr) * 2005-01-04 2006-07-07 Jean Marc Ruiz Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication
EP1928423B1 (en) 2005-09-14 2015-12-09 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
ES2647080T3 (es) 2006-02-22 2017-12-19 Mannkind Corporation Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo
US20080033038A1 (en) * 2006-07-07 2008-02-07 Shytle R D Compositions of polyphenols and methods of use
WO2008078730A1 (ja) * 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
DK2211842T3 (en) * 2007-10-24 2015-09-21 Mannkind Corp An inhalable dry powder formulation COMPREHENSIVE GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCAEMIA AND DIABETES BY pulmonary delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2567723B1 (en) 2008-06-13 2021-01-20 MannKind Corporation A dry powder inhaler and system for drug delivery
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (en) 2009-03-11 2017-03-01 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
KR20210027546A (ko) 2009-06-12 2021-03-10 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
KR20130117755A (ko) 2010-06-21 2013-10-28 맨카인드 코포레이션 건조 분말 약물 운반 시스템 및 방법
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
MX369136B (es) 2013-03-15 2019-10-30 Mannkind Corp Composiciones de dicetopiperazina microcristalina y metodos.
KR102465025B1 (ko) 2013-07-18 2022-11-09 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
CN103638527A (zh) * 2013-12-05 2014-03-19 浙江大学 促红细胞生成素载药纳米粒及其应用
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
CN106362158A (zh) * 2015-07-25 2017-02-01 于杰 增效药物
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917563B1 (el) * 1970-12-28 1974-05-01
US4613500A (en) * 1983-03-09 1986-09-23 Teijin Limited Powdery pharmaceutical composition for nasal administration
JPS62223131A (ja) * 1986-03-26 1987-10-01 Nitto Electric Ind Co Ltd 持続性鼻疾患治療剤
EP0606486A1 (en) * 1992-06-12 1994-07-20 Teijin Limited Pharmaceutical preparation for intra-airway administration
FR2736547A1 (fr) * 1995-07-12 1997-01-17 Ltt Inst Co Ltd Medicament pour administration nasale

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB792544A (en) * 1956-05-07 1958-03-26 American Home Prod Therapeutic composition
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
US5342922A (en) * 1989-03-08 1994-08-30 Washington University Inhibitors of retroviral protease
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
EP0659728A4 (en) * 1992-09-10 1997-08-06 Teijin Ltd 4-HYDROXY-2-CYCLOPENTENONE DERIVATIVES AND CARCINOSTATICS AND OSTEOGENESIS PROMOTERS CONTAINING THEM.
CA2114830C (en) * 1993-02-05 2000-06-06 Masayasu Tabe Lactone compound and process of production thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917563B1 (el) * 1970-12-28 1974-05-01
US4613500A (en) * 1983-03-09 1986-09-23 Teijin Limited Powdery pharmaceutical composition for nasal administration
JPS62223131A (ja) * 1986-03-26 1987-10-01 Nitto Electric Ind Co Ltd 持続性鼻疾患治療剤
EP0606486A1 (en) * 1992-06-12 1994-07-20 Teijin Limited Pharmaceutical preparation for intra-airway administration
FR2736547A1 (fr) * 1995-07-12 1997-01-17 Ltt Inst Co Ltd Medicament pour administration nasale

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 7421, Derwent World Patents Index; Class A96, AN 74-39365V, XP002112124 *
PATENT ABSTRACTS OF JAPAN vol. 012, no. 084 (C - 482) 17 March 1988 (1988-03-17) *
RYDEN, L. ET AL: "Potential use of polymers and spheres as nasal drug delivery systems", PROC. PROGRAM INT. SYMP. CONTROLLED RELEASE BIOACT. MATER., 18TH (1991), 495-6. EDITOR(S): KELLAWAY, IAN W. PUBLISHER: CONTROLLED RELEASE SOC., DEERFIELD, ILL., XP002112123 *

Also Published As

Publication number Publication date
GB2322077A (en) 1998-08-19
SE9703133D0 (sv) 1997-08-29
FR2754453A1 (fr) 1998-04-17
FI973244A (fi) 1998-04-08
NO974618D0 (no) 1997-10-06
DK114797A (da) 1998-04-08
US5948749A (en) 1999-09-07
JPH10114645A (ja) 1998-05-06
GB9718690D0 (en) 1997-11-12
CN1180569A (zh) 1998-05-06
ES2126536A1 (es) 1999-03-16
AU3992697A (en) 1998-04-09
FI973244A0 (fi) 1997-08-06
KR19980032364A (ko) 1998-07-25
SE9703133L (sv) 1998-04-08
CA2217409A1 (en) 1998-04-07
JP3020141B2 (ja) 2000-03-15
DE19740733A1 (de) 1998-04-09
IT1295047B1 (it) 1999-04-27
NO974618L (no) 1998-04-08
ES2126536B1 (es) 1999-10-01
ITMI972144A1 (it) 1999-03-22

Similar Documents

Publication Publication Date Title
GR970100333A (el) Φαρμακευτικα παρασκευασματα για ενδορρινικη χορηγηση
IL139235A0 (en) Pharmaceutical preparations
PL320856A1 (en) Aerosol drug preparations
AP9801392A0 (en) Concentrated antibody preparation.
GR3035410T3 (en) Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions
IL131259A0 (en) Topical drug preparations
EP0753293A3 (de) Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparate
HUP9603071A3 (en) Purin-6-one derivatives, producing and pharmaceuticals preparations containing them
AU1192892A (en) Pharmaceutical preparation of antistress, stress-preventive and nootropic action
AU8072691A (en) Pharmaceutical preparations
AU1638095A (en) Boronic peptide derivatives, preparation and therapeutic application thereof
IL116912A0 (en) Novel pharmaceutical combination for topical administration
AU5693296A (en) Pectic preparations used as medicament carriers
AU6820796A (en) Antigenic preparations
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
PL328763A1 (en) Misolastin containing pharmaceutical preparations of prolonged action
GB2314271B (en) Therapeutic methods and preparations using rubidium ions
AU3552797A (en) Vaccine preparations
AU1800100A (en) Medicinal preparations
AUPM855194A0 (en) Controlled-release pharmaceutical preparations
AU691677B2 (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
HUP9602220A3 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
ZA934523B (en) Medicinal preparation
AU3599995A (en) Controlled-release pharmaceutical preparations